Related Experiment Video
Updated: Apr 26, 2026

Determination of Vaccine Immunogenicity Using Bovine Monocyte-Derived Dendritic Cells
Published on: May 19, 2023
Bovine rotavirus pentavalent vaccine development in India
Jagdish K Zade1, Prasad S Kulkarni1, Sajjad A Desai1
1Serum Institute of India Ltd., Pune, India.
Abstract:
A bovine rotavirus pentavalent vaccine (BRV-PV) containing rotavirus human-bovine (UK) reassortant strains of serotype G1, G2, G3, G4 and G9 has been developed by the Serum Institute of India Ltd, in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), USA. The vaccine underwent animal toxicity studies and Phase I and II studies in adults, toddlers and infants. It has been found safe and immunogenic and will undergo a large Phase III study to assess efficacy against severe rotavirus gastroenteritis.
More Related Videos
Related Concept Videos
Vaccine Production
Bacterial Gastroenteritis

